SEARCH

HOME / SEARCH / Crenolanib

iGMDRD413

Canonical SMILES: CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4

InChI: InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3

InChI Key: DYNHJHQFHQTFTP-UHFFFAOYSA-N

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Crenolanib	CHEMBL2105728	10366100	DB11832	Alone	Small Molecule

Drug Class:

Antineoplastic Agents Heterocyclic Compounds Heterocyclic Compounds, 1-Ring Heterocyclic Compounds, 2-Ring Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Gene ID	Gene Name	Model Num.
2322	FLT3	2
5156	PDGFRA	16

Gene in drug-gene network: Network Plot

Models in Crenolanib

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.